Related Experiment Videos
High-risk carotid endarterectomy
1Division of Vascular Surgery, Mayo Clinic and Mayo Medical School, Rochester, MN 55905, USA. mozes.geza@mayo.edu
Seminars in Vascular Surgery
|June 30, 2005
Summary
Most "high-risk" carotid endarterectomy (CEA) patients can undergo the procedure safely. Age alone is not a high-risk factor, but specific conditions like prior radiation increase risks.
Area of Science:
- Vascular Surgery
- Cerebrovascular Disease Management
Background:
- Defining
- high-risk
- carotid endarterectomy (CEA) is crucial for patient selection and optimizing outcomes.
- Previous randomized controlled trials (RCTs) excluded many patients, leading to a potentially narrow definition of high-risk cases.
Purpose of the Study:
- To critically evaluate the concept of
- high-risk
- CEA by reviewing diverse evidence.
- To identify specific risk factors that genuinely increase perioperative morbidity and mortality during CEA.
- To inform appropriate patient selection for CEA and alternative interventions like carotid artery stenting (CAS).
Main Methods:
- Comprehensive literature review encompassing controlled randomized trials, retrospective population-based studies, large institution-based studies, and case series.
- Analysis of evidence regarding the impact of various patient characteristics and clinical scenarios on CEA outcomes.
Main Results:
- CEA can be safely performed in most patients previously considered
- high-risk
- , with low mortality and morbidity.
- Age (≥80 years) alone is not a significant high-risk criterion.
- Factors associated with slightly increased risk include contralateral carotid occlusion, carotid reoperation, and CEA after cervical radiation therapy.
Conclusions:
- The broad exclusion criteria from early CEA trials do not justify a restrictive approach to
- high-risk
- patients.
- Specific individual risk factors, such as prior radiation or reoperation, warrant careful consideration.
- Carotid artery stenting (CAS) should be reserved for well-defined high-risk patients due to limited evidence on its long-term efficacy compared to CEA.